BIIB Biogen Inc
NASDAQ · USD · scheduled refresh; check source timestamp Insiders net selling (90d) — usually routine☪ Non-compliant · TEST$215.50
-3.55 (-1.62%)
Price session: 2026-09-18 · Observed: 18 Sept 2026, 23:00 KSA · Source: live quote
41
Easy Score
WeakOne number from three engines — value 24، momentum 39، trend 60 (0–100). Analysis, not financial advice.
Why is it moving? auto-generated from price, volume, signals, news
BIIB -1.62% today · volume 3.7× the 20-day average — unusual activity · 3 recent headlines — latest not assessed: “Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of N…”.
Price interactive — your checked tools draw on it
Daily is the finest granularity · last ~6 months
RSI (14)
Patterns detected:
CloseMA 50MA 200check tools below to add them to the chart
Key technicals & risk same math as the same engine as the Overview page
RSI (14)50.4
MACD hist.-0.65
50-day MA$210.56
200-day MA$192.84
ATR (14)$5.63
Avg volume (20d)0.8M
Volatility (ann.)35%
Max drawdown (1y)-14%
Beta vs S&P0.37
Daily plain-language briefs are a Pro feature.
Forecast two independent reads
System
USD 210.07USD 220.13
Yours · 2 toolsUSD 212.19USD 222.34
NowUSD 215.50USD 209.34USD 223.08
Computed from: USD 215.50 · session 2026-09-18 · 2509 historical windows
Lean score +0.43 — 1 bullish / 0 bearish / 1 neutral among your checked tools, weighted for this horizon. Your overlay is an exploratory scenario, not a calibrated prediction. The historical baseline stays unchanged. The system band is the 25th–75th percentile of this stock's own historical moves for the horizon.
Technical indicators
Checked 2 of 2 allowed on Free plan
Sign in to save your tool selection per stock.
Street consensus: 30 buy / 12 hold / 1 sell of 43 analysts
My notes on BIIB private investment journal
Sign in to keep a dated journal per stock — your thesis lives next to the data.